Ameriprise’s Claritev Corp CTEV Stock Holding History

Ameriprise’s Portfolio CTEV Stock Details CTEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-48,594	Closed	-$10.7M	–	4038
2022 Q2	$10.7M	Buy	+48,594	New	+$9.61M	﹤0.01%	1692

Other funds holding CTEV

HFCIV

H&F Corporate Investors VIII San Francisco, California $133M AUM 24.42% 1-Year Est. Return

PIF

Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $37.9B AUM 7.98% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CPV Partners Stamford, Connecticut $274M AUM 43.74% 1-Year Est. Return

BPCM

Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return

Ares Management Los Angeles, California $2.29B AUM 0.27% 1-Year Est. Return

Ameriprise's CTEV Position: Q3 2022 in Review

Ameriprise sold out of Claritev Corp (CTEV) in Q3 2022, closing a stake of 48,594 shares — an estimated $10.7M sold.

Ameriprise first reported a position in CTEV in Q2 2022 and held it in 1 quarter. The position peaked at $10.7M in Q2 2022. 130 funds tracked by Wall St. Rank hold CTEV as of Q3 2022.

Ameriprise reported no remaining Claritev Corp position as of Q3 2022 after selling out during the quarter.
Ameriprise sold 48,594 Claritev Corp shares in Q3 2022, an estimated $10.7M.
Ameriprise first reported a position in Claritev Corp in Q2 2022 and held it in 1 quarter.
Ameriprise's Claritev Corp position peaked at $10.7M in Q2 2022.
130 funds tracked by Wall St. Rank held Claritev Corp as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.